Holleran B - Search Results

1

The urotensin II receptor triggers an early meningeal response and a delayed macrophage-dependent vasospasm after subarachnoid hemorrhage in male mice.

Pedard M, Prevost L, Carpena C, Holleran B, Desrues L, Dubois M, Nicola C, Gruel R, Godefroy D, Deffieux T, Tanter M, Ali C, Leduc R, Prézeau L, Gandolfo P, Morin F, Wurtz O, Bonnard T, Vivien D, Castel H. Pedard M, et al. Among authors: holleran b. Nat Commun. 2024 Sep 29;15(1):8430. doi: 10.1038/s41467-024-52654-2. Nat Commun. 2024. PMID: 39341842 Free PMC article.

2

Biological properties and functional determinants of the urotensin II receptor.

Proulx CD, Holleran BJ, Lavigne P, Escher E, Guillemette G, Leduc R. Proulx CD, et al. Peptides. 2008 May;29(5):691-9. doi: 10.1016/j.peptides.2007.10.027. Epub 2007 Nov 17. Peptides. 2008. PMID: 18155322 Review.

3

Mutational analysis of the conserved Asp2.50 and ERY motif reveals signaling bias of the urotensin II receptor.

Proulx CD, Holleran BJ, Boucard AA, Escher E, Guillemette G, Leduc R. Proulx CD, et al. Mol Pharmacol. 2008 Sep;74(3):552-61. doi: 10.1124/mol.108.045054. Epub 2008 May 28. Mol Pharmacol. 2008. PMID: 18509066

4

Identification of transmembrane domain 1 & 2 residues that contribute to the formation of the ligand-binding pocket of the urotensin-II receptor.

Sainsily X, Cabana J, Holleran BJ, Escher E, Lavigne P, Leduc R. Sainsily X, et al. Biochem Pharmacol. 2014 Nov 15;92(2):280-8. doi: 10.1016/j.bcp.2014.08.023. Epub 2014 Aug 29. Biochem Pharmacol. 2014. PMID: 25175740

5

Photolabelling the urotensin II receptor reveals distinct agonist- and partial-agonist-binding sites.

Holleran BJ, Beaulieu ME, Proulx CD, Lavigne P, Escher E, Leduc R. Holleran BJ, et al. Biochem J. 2007 Feb 15;402(1):51-61. doi: 10.1042/BJ20060943. Biochem J. 2007. PMID: 17064254 Free PMC article.

6

Identification of transmembrane domain 3, 4 & 5 residues that contribute to the formation of the ligand-binding pocket of the urotensin-II receptor.

Sainsily X, Cabana J, Boulais PE, Holleran BJ, Escher E, Lavigne P, Leduc R. Sainsily X, et al. Biochem Pharmacol. 2013 Dec 1;86(11):1584-93. doi: 10.1016/j.bcp.2013.09.015. Epub 2013 Sep 29. Biochem Pharmacol. 2013. PMID: 24084430

7

Critical hydrogen bond formation for activation of the angiotensin II type 1 receptor.

Cabana J, Holleran B, Beaulieu MÈ, Leduc R, Escher E, Guillemette G, Lavigne P. Cabana J, et al. Among authors: holleran b. J Biol Chem. 2013 Jan 25;288(4):2593-604. doi: 10.1074/jbc.M112.395939. Epub 2012 Dec 7. J Biol Chem. 2013. PMID: 23223579 Free PMC article.

8

Identification of transmembrane domain 6 & 7 residues that contribute to the binding pocket of the urotensin II receptor.

Holleran BJ, Domazet I, Beaulieu ME, Yan LP, Guillemette G, Lavigne P, Escher E, Leduc R. Holleran BJ, et al. Biochem Pharmacol. 2009 Apr 15;77(8):1374-82. doi: 10.1016/j.bcp.2009.01.013. Epub 2009 Jan 29. Biochem Pharmacol. 2009. PMID: 19426676

9

Gα_s protein binds ubiquitin to regulate epidermal growth factor receptor endosomal sorting.

Li X, Létourneau D, Holleran B, Leduc R, Lavigne P, Lavoie C. Li X, et al. Among authors: holleran b. Proc Natl Acad Sci U S A. 2017 Dec 19;114(51):13477-13482. doi: 10.1073/pnas.1708215114. Epub 2017 Nov 30. Proc Natl Acad Sci U S A. 2017. PMID: 29192023 Free PMC article.

10

Activation of the angiotensin II type 1 receptor leads to movement of the sixth transmembrane domain: analysis by the substituted cysteine accessibility method.

Martin SS, Holleran BJ, Escher E, Guillemette G, Leduc R. Martin SS, et al. Mol Pharmacol. 2007 Jul;72(1):182-90. doi: 10.1124/mol.106.033670. Epub 2007 Apr 19. Mol Pharmacol. 2007. PMID: 17446269

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters